valsartan has been researched along with Wounds and Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abadir, P; Ansari, A; Berger, A; Beselman, A; Budman, J; Faghih, M; Fedarko, N; Harmon, J; Hosseini, S; Inagami, T; Keenahan, K; Lay, F; Marti, G; Rini, D; Smith, B; Tian, J; Vuong, D; Walston, J | 1 |
Horiuchi, M; Ide, A; Ito, M; Iwai, M; Mogi, M; Okumura, M | 1 |
2 other study(ies) available for valsartan and Wounds and Injuries
Article | Year |
---|---|
Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds.
Topics: Administration, Cutaneous; Alloxan; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Diabetes Mellitus, Experimental; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Skin; Swine; Swine, Miniature; Time Factors; Treatment Outcome; Valsartan; Wound Healing; Wounds and Injuries | 2018 |
Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Female; Femoral Artery; Male; Mice; Mice, Knockout; Oxidative Stress; Receptor, Angiotensin, Type 2; Sex Characteristics; Tetrazoles; Valine; Valsartan; Vasculitis; Wounds and Injuries | 2005 |